Evidence map›Paper›PMID 17429973›Full record

ArticleJournal of the American Chemical Society2007

GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.

Jinjun Shi, Tinglu Yang, Sho Kataoka, Yanjie Zhang, Arnaldo J Diaz, Paul S Cremer

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 193 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Which Moiety Drives Gangliosides to Form Nanodomains?The journal of physical chemistry letters · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Recombination betweenAnalytical chemistry · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jinjun ShiDepartment of Chemistry, Texas A&M University, P.O. Box 30012, College Station, Texas 77843-3012, USA.
Tinglu Yang
Sho Kataoka
Yanjie Zhang
Arnaldo J Diaz
Paul S Cremer
Texas A&M University · US

Funding

Multivalent Ligand-Receptor Binding on Lipid BilayersR01GM070622 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI CREMER, PAUL · 2004 to 2012
$2.2M
NIGMS NIH HHS R01 GM070622PHS HHS R01-070622
6 · The paper itself

Abstract

The present studies explore multivalent ligand-receptor interactions between pentameric cholera toxin B subunits (CTB) and the corresponding membrane ligand, ganglioside GM1. CTB binding was monitored on supported phospholipid bilayers coated on the walls and floors of microfluidic channels. Measurements were made by total internal reflection fluorescence microscopy (TIRFM). Apparent dissociation constants were extracted by fitting the binding data to both the Hill-Waud and Langmuir adsorption isotherm equations. Studies of the effect of ligand density on multivalent CTB-GM1 interactions revealed that binding weakened with increasing GM1 density from 0.02 mol % to 10.0 mol %. Such a result could be explained by the clustering of GM1 on the supported phospholipid membranes, which in turn inhibited the binding of CTB. Atomic force microscopy (AFM) experiments directly verified GM1 clustering within the supported POPC bilayers.

Indexed as

Cholera ToxinG(M1) GangliosideLigandsMembrane LipidsMicrofluidicsPhospholipidsProtein BindingCholera ToxinG(M1) GangliosideLigandsMembrane LipidsPhospholipids

Identifiers

PMID17429973
PMCPMC3475181
OpenAlexW2017645455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.